Clinical Trials in New York

Showing 12061-12080 of 22,668 trials

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

NCT02406651

A Phase IIa single arm open-label study to investigate the safety, tolerability, and PK of F-652 in combination with systemic corticosteroids in subjects who have undergone Hematopoietic Stem Cell Transplantation (HSCT) and have newly diagnosed grade II-IV lower GI acute Graft Verses Host Disease (aGVHD). Treatment with F-652 will be once a week for 4 weeks, with post treatment follow up visits on days 28, 56, 180 and 365.

Acute Graft vs Host Disease

EVIVE Biotechnology30 participantsStarted May 2016

Duarte, California, United States • New York, New York, United States • Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

NCT02207244

The purpose of this study is to evaluate the efficacy, safety, and tolerability of guselkumab (CNTO 1959) in the treatment of participants with moderate to severe plaque-type psoriasis (scaly skin rash).

Psoriasis

Janssen Research & Development, LLC992 participantsStarted Nov 2014

Birmingham, Alabama, United States • Bakersfield, California, United States • Los Angeles, California, United States +90 more locations

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Find Trials by Condition in New York

Natural History Study of MNGIE

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages

Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder

Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Pain Screening in Refugee Survivors of Torture

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Phase 2/3 Study of IGSC, 20% in PIDD

Remote Bimanual Virtual Rehabilitation Post CVD

Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers

Evaluation of Brain Activity Changes After a Behavior Change Weight Loss Intervention

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

Breast Mesh Used in Two-staged Breast Reconstruction

Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A